APA (7th ed.) Citation

Yang, W., Kim, D., Kang, S., Lai, C., Cha, I., Chang, P., & Jung, J. U. Development of KSHV vaccine platforms and chimeric MHV68-K-K8.1 glycoprotein for evaluating the in vivo immunogenicity and efficacy of KSHV vaccine candidates. American Society for Microbiology.

Chicago Style (17th ed.) Citation

Yang, Wan-Shan, Dokyun Kim, Soowon Kang, Chih-Jen Lai, Inho Cha, Pei-Ching Chang, and Jae U. Jung. Development of KSHV Vaccine Platforms and Chimeric MHV68-K-K8.1 Glycoprotein for Evaluating the in Vivo Immunogenicity and Efficacy of KSHV Vaccine Candidates. American Society for Microbiology.

MLA (9th ed.) Citation

Yang, Wan-Shan, et al. Development of KSHV Vaccine Platforms and Chimeric MHV68-K-K8.1 Glycoprotein for Evaluating the in Vivo Immunogenicity and Efficacy of KSHV Vaccine Candidates. American Society for Microbiology.